Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|May 19, 2022
Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian CarcinomaBrooke E Sanders, Tomomi M Yamamoto, Alexandra McMellen, et al.
Obstetrics and Gynecology|January 4, 2024
Early Ovarian Cancer Detection in the Age of Fallopian Tube Precursors: A Systematic ReviewAshley Greenwood, Elizabeth R Woodruff, Cam Nguyen, et al.
Scientific Reports|November 10, 2025
Claudin-4 as a dual regulator of genome stability and immune evasion in high grade serous ovarian cancerBenjamin G Bitler, Julie Lang, Daniel Nunez-Avellaneda, et al.
Cancer Research Communications|June 13, 2024
Claudin-4 Modulates Autophagy via SLC1A5/LAT1 as a Mechanism to Regulate MicronucleiFabian R Villagomez, Julie Lang, Fredrick J Rosario, et al.
Eneuro|January 11, 2019
Coordination between Prefrontal Cortex Clock Gene Expression and Corticosterone Contributes to Enhanced Conditioned Fear Extinction RecallElizabeth R Woodruff, Lauren E Chun, Laura R Hinds, et al.
Molecular Cancer Therapeutics|January 24, 2026
Chromobox2 inhibition: a novel activity of alisertib, an aurora A kinase inhibitorTomomi M Yamamoto, Ritsuko Iwanaga, Elizabeth R Woodruff, et al.
Molecular Cancer Therapeutics|April 4, 2022
Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP InhibitorsTomomi M Yamamoto, Patricia G Webb, Dana M Davis, et al.
Cancer Gene Therapy|November 29, 2023
CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFRJaidev Bapat, Tomomi M Yamamoto, Elizabeth R Woodruff, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Claudin-4 remodeling of nucleus-cell cycle crosstalk maintains ovarian tumor genome stability and drives resistance to genomic instability-inducing agentsFabian R Villagomez, Julie Lang, Daniel Nunez-Avellaneda, et al.
Cancer Research Communications|December 3, 2024
Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell SurvivalFabian R Villagomez, Julie Lang, Daniel Nunez-Avellaneda, et al.
Pageof 3